MedTrace Logo

Ondansetron for Postspinal Anesthesia Hypotension

NCT05475873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-11-02

No results posted yet for this study

Summary

The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.

Conditions

  • Adverse Effect

Interventions

DRUG

normal saline

A bolus of normal saline (2 ml) by IV was given 5 min before spinal anesthesia.

DRUG

Ondansetron 4 mg

A bolus of ondansetron (2 ml; 4mg) by IV was given 5 min before spinal anesthesia.

DRUG

Ondansetron 8 mg

A bolus of ondansetron (2 ml; 8mg) by IV was given 5 min before spinal anesthesia.

Sponsors & Collaborators

  • General Hospital of Ningxia Medical University

    lead OTHER

Principal Investigators

  • Yi Chen, M.D. · General Hospital of Ningxia Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-18
Primary Completion
2023-10-27
Completion
2023-10-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05475873 on ClinicalTrials.gov